My COVID Journey

By Sharmin Sultana — Jan 03, 2022
I immigrated to the U.S. in February 2020, not knowing that going back home would not be easy. Two weeks later, international travel was banned due to an unpredicted outbreak of COVID-19, and I was trapped ...

I immigrated to the U.S. in February 2020, not knowing that going back home would not be easy. Two weeks later, international travel was banned due to an unpredicted outbreak of COVID-19, and I was trapped ...

Refuting 'Crazy Joe' Mercola's Glyphosate-Autism Scare Story

By Cameron English — Dec 31, 2021
Alternative health guru Joe Mercola claims there's been a massive increase in autism cases since the 1960s and that the weedkiller glyphosate is a "key culprit." He's wrong on both points.

Alternative health guru Joe Mercola claims there's been a massive increase in autism cases since the 1960s and that the weedkiller glyphosate is a "key culprit." He's wrong on both points.

Our Top 10

By Chuck Dinerstein, MD, MBA — Dec 31, 2021
It is that time of year when we present listicles of our top 5 or 10. Here are our most popular articles based on your page views. On behalf of myself and all of our wonderful writers, thank you for all 400,000 reads.

It is that time of year when we present listicles of our top 5 or 10. Here are our most popular articles based on your page views. On behalf of myself and all of our wonderful writers, thank you for all 400,000 reads.

Our COVID-19 Research Summary - 2021         

By Fred Lipfert, PhD — Dec 31, 2021
The published literature on COVID now exceeds 211,000 papers, books, and documents, which include: 22,866 observational studies, 19,591 reviews, 1496 meta-analyses and 781 randomized control trials. These publications comprise the backdrop for our research and writing. The project began in the spring of 2020 based on a limited source of cumulative COVID-19 data and has broadened considerably. Here is what we have learned.

The published literature on COVID now exceeds 211,000 papers, books, and documents, which include: 22,866 observational studies, 19,591 reviews, 1496 meta-analyses and 781 randomized control trials. These publications comprise the backdrop for our research and writing. The project began in the spring of 2020 based on a limited source of cumulative COVID-19 data and has broadened considerably. Here is what we have learned.

There Are Now 2 New COVID Antivirals. Which One's For You?

By Josh Bloom — Dec 30, 2021
All of a sudden we have two (provisionally) FDA-approved COVID antivirals, which will be in pharmacies soon. They are quite different. Which is best for you?

All of a sudden we have two (provisionally) FDA-approved COVID antivirals, which will be in pharmacies soon. They are quite different. Which is best for you?

'Woke' Scientific American Goes Anti-GMO

By Cameron English — Dec 29, 2021
Scientific American's descent from respected publication to ideological tabloid is nearly complete. The magazine is now promoting anti-GMO activism under the guise of "social justice."

Scientific American's descent from respected publication to ideological tabloid is nearly complete. The magazine is now promoting anti-GMO activism under the guise of "social justice."

COVID-19: After Cases Surged, Did 'Acquired' Immunity Linger?

By Fred Lipfert, PhD — Dec 29, 2021
Two sources of immunity from infectious diseases are widely recognized: vaccination and immunity acquired naturally in survivors of previous infections. The latter may be involved in the roller-coaster up-and-down behavior seen in the progression of daily new COVID cases after the current pandemic began in early 2020. Cases increased as the virus spread throughout the nation, in part due to insufficient attention to limiting exposures, but what could account for subsequent decreases? We (and others) ascribe the long downward slide from the 2020-21 winter peak to the coincident national vaccination program. Here we set out to investigate possible contributions from infection-acquired immunity.

Two sources of immunity from infectious diseases are widely recognized: vaccination and immunity acquired naturally in survivors of previous infections. The latter may be involved in the roller-coaster up-and-down behavior seen in the progression of daily new COVID cases after the current pandemic began in early 2020. Cases increased as the virus spread throughout the nation, in part due to insufficient attention to limiting exposures, but what could account for subsequent decreases? We (and others) ascribe the long downward slide from the 2020-21 winter peak to the coincident national vaccination program. Here we set out to investigate possible contributions from infection-acquired immunity.

Vaping Helps Smokers Quit — Even When They Don't Plan To

By Cameron English — Dec 28, 2021
Multiple studies have shown that vaping can help smokers give up cigarettes if they want to quit. But research is beginning to show that vaping may actually incentivize smokers to quit, even when they have no plans to stop.

Multiple studies have shown that vaping can help smokers give up cigarettes if they want to quit. But research is beginning to show that vaping may actually incentivize smokers to quit, even when they have no plans to stop.

NBC's Shameless Attempt to Scare You About Pfizer's COVID Drug

By Josh Bloom — Dec 28, 2021
We are fortunate enough that there is now an FDA-approved drug called Paxlovid, which does an incredible job of keeping COVID patients out of the hospital (or morgue). Yet NBCNews.com chose a sensationalist, scary headline about the drug as its lead health story of the day. Really lousy journalism.

We are fortunate enough that there is now an FDA-approved drug called Paxlovid, which does an incredible job of keeping COVID patients out of the hospital (or morgue). Yet NBCNews.com chose a sensationalist, scary headline about the drug as its lead health story of the day. Really lousy journalism.